Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Pozycja w akcjach #40953
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Cena akcji
$0.15137669
Kapitalizacja rynkowa
$58.28K
Zmiana (1 dzień)
11.25%
Zmiana (1 rok)
6.17%
Kraj
VG
Handel CRISM Therapeutics Corporation (CRTX)

Kategoria

Historia stopy dywidendy dla CRISM Therapeutics Corporation (CRTX)
Stopa dywidendy (TTM) dla CRISM Therapeutics Corporation (symbol akcji: CRTX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla CRISM Therapeutics Corporation (CRTX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji